Does ashwagandha cause hair loss? It is a question increasingly asked by UK consumers turning to this popular Ayurvedic adaptogen for stress relief, sleep support, and hormonal balance. Ashwagandha (Withania somnifera) is widely available in UK health food shops and pharmacies as an unregulated food supplement, yet its effects on hair remain poorly understood. This article examines the current clinical evidence, explores the biological mechanisms that have been proposed, outlines other common causes of hair loss, and explains when to seek advice from a GP or pharmacist.

What Is Ashwagandha and How Is It Used in the UK?

Ashwagandha is an Ayurvedic adaptogen widely sold in the UK as a food supplement in capsule, powder, and liquid form, regulated under food supplement legislation rather than medicines law, with no current MHRA Traditional Herbal Registration.

Ashwagandha (Withania somnifera) is a medicinal herb with roots in Ayurvedic medicine, a traditional system of healing originating in India. It is classified as an adaptogen — a substance believed to help the body manage physical and psychological stress. In the UK, ashwagandha is widely available as an over-the-counter food supplement in capsule, powder, and liquid extract forms, sold in health food shops, pharmacies, and online retailers.

The herb contains a range of active compounds, most notably withanolides, which are thought to modulate the hypothalamic-pituitary-adrenal (HPA) axis and may influence circulating cortisol levels, though effects vary across preparations and study populations. As a result, ashwagandha is commonly marketed to support stress relief, sleep quality, energy levels, and cognitive function. Some products also claim benefits for hormonal balance and physical performance.

In the UK, ashwagandha supplements are regulated as food supplements rather than medicines. Health and nutrition claims for food supplements must be authorised on the Great Britain Nutrition and Health Claims Register; permitted claims are overseen by the Office for Product Safety and Standards (OPSS) and enforced by the Advertising Standards Authority (ASA) and the Committee of Advertising Practice (CAP). The Medicines and Healthcare products Regulatory Agency (MHRA) does not approve food supplement health claims, though it may classify a product as a borderline medicine if it makes medicinal claims. There is currently no Traditional Herbal Registration (THR) granted for any ashwagandha product on the MHRA THR public register, unlike some other herbal remedies such as valerian or echinacea.

Because food supplements are not subject to the same rigorous pre-market clinical testing required of licensed pharmaceutical products, quality, purity, and withanolide content can vary significantly between brands. Consumers should purchase from reputable suppliers who can provide certificates of analysis, approach marketing claims with appropriate caution, and consult a healthcare professional before starting any new supplement — particularly if they have an existing medical condition or are taking prescribed medication.

What the Current Evidence Says About Ashwagandha and Hair

No robust clinical evidence links ashwagandha to hair loss; proposed mechanisms involving testosterone, thyroid stimulation, and cortisol changes remain speculative and are not confirmed by direct clinical data.

Not sure if this is normal? Chat with one of our pharmacists →

The question of whether ashwagandha causes hair loss has gained traction online, but it is important to distinguish between anecdotal reports and clinical evidence. At present, there is no robust clinical evidence directly linking ashwagandha supplementation to hair loss in peer-reviewed literature. Reviews of available clinical trial safety data do not identify alopecia as a recognised adverse effect of ashwagandha, and there are no published case reports attributing hair loss directly to its use.

Nonetheless, some biological mechanisms have been proposed that are worth noting, though these remain speculative and are not supported by direct clinical evidence:

• Hormonal effects: Some small randomised controlled trials have shown modest increases in testosterone in specific male populations taking ashwagandha. Dihydrotestosterone (DHT) — a potent androgen derived from testosterone — is a well-established driver of androgenetic alopecia (pattern hair loss). However, there is no direct clinical evidence that ashwagandha raises DHT levels or causes hair loss through this pathway. Any such effect, if it exists, would most plausibly affect only those with a genetic predisposition to androgenetic alopecia.

• Thyroid interactions: There is limited evidence from case reports that ashwagandha may stimulate thyroid hormone production. Both hyperthyroidism and hypothyroidism are recognised causes of diffuse hair shedding (telogen effluvium), so individuals with thyroid conditions should exercise particular caution. This is discussed further in the safety section below.

• Stress and cortisol: It has been suggested, as a hypothesis only, that changes in cortisol levels could theoretically contribute to temporary hair shedding in susceptible individuals. This is not supported by clinical evidence and should not be taken as an established mechanism.

It is worth emphasising that individual responses to supplements vary considerably. If someone notices hair loss after starting ashwagandha, this may be coincidental rather than causal. Correlation does not imply causation, and a thorough clinical assessment is always necessary before attributing hair loss to any single factor.

Other Factors That May Contribute to Hair Loss

Hair loss is multifactorial; common causes include androgenetic alopecia, telogen effluvium, iron deficiency, thyroid disorders, medications, and autoimmune conditions, which should be excluded before attributing shedding to any supplement.

Hair loss is a multifactorial condition, and in many cases where individuals report shedding after starting ashwagandha, other underlying causes are likely to be responsible. Understanding these factors is essential for accurate diagnosis and appropriate management.

Common causes of hair loss include:

• Androgenetic alopecia: The most prevalent form of hair loss in both men and women, driven by genetic sensitivity to DHT. It typically presents as gradual, patterned thinning.

• Telogen effluvium: A diffuse, temporary shedding triggered by physiological stressors such as illness, surgery, significant weight loss, or emotional stress. It commonly occurs two to three months after the triggering event, which can make identifying the true cause difficult. Postpartum hair shedding is a well-recognised form.

• Nutritional deficiencies: Iron deficiency and low ferritin are among the better-established nutritional contributors to hair thinning and shedding. Evidence for vitamin D and B vitamins as direct causes is more variable, and their relevance should be assessed in the context of individual clinical features.

• Thyroid disorders: Both an underactive (hypothyroidism) and overactive (hyperthyroidism) thyroid can cause diffuse hair loss and should be excluded with appropriate blood tests.

• Medications: A wide range of prescribed medicines — including anticoagulants, antidepressants, retinoids, and hormonal contraceptives — are known to cause hair loss as a side effect.

• Autoimmune conditions: Alopecia areata, lupus, and other autoimmune disorders can present with patchy or diffuse hair loss.

• Scalp and skin conditions: Tinea capitis (scalp ringworm), scarring alopecias such as lichen planopilaris, and traction alopecia from prolonged mechanical tension on the hair are important differentials that may require specialist assessment.

Given this complexity, it is rarely appropriate to attribute hair loss solely to a supplement without first ruling out these more common and clinically significant causes through a structured medical assessment. The NHS, the Primary Care Dermatology Society (PCDS), and the British Association of Dermatologists (BAD) all provide patient-facing information on the range of causes and available treatments.

When to Speak to a GP or Pharmacist About Hair Loss

See your GP if you experience sudden, patchy, or progressive hair loss, especially if accompanied by scalp changes or systemic symptoms such as fatigue or weight changes, as investigations including ferritin and thyroid function tests may be warranted.

Hair loss can be distressing, and knowing when to seek professional advice is important for both physical and psychological wellbeing. While some degree of daily hair shedding (typically up to around 100 hairs per day) is entirely normal, certain patterns and symptoms warrant prompt medical attention.

You should speak to your GP if you notice:

• Sudden or rapid hair loss over a short period

• Patchy bald areas on the scalp, eyebrows, or beard

• Hair loss accompanied by scalp redness, scaling, itching, pain, or scarring — these features may require more urgent assessment

• Diffuse thinning that appears to be worsening progressively

• Hair loss alongside other symptoms such as fatigue, weight changes, or irregular periods, which may suggest an underlying systemic condition

• Hair loss that is causing significant psychological distress

Your GP will tailor investigations to your history and examination findings. Tests commonly considered in primary care include a full blood count (FBC), serum ferritin, and thyroid function tests (TFTs). Additional tests — such as androgen levels, prolactin, vitamin D, or a coeliac screen — are generally only arranged when there are specific clinical features to suggest they are relevant, in line with NICE Clinical Knowledge Summaries (CKS) and PCDS guidance on alopecia in adults. Routine testing of all these markers without clinical indication is not standard practice.

If specialist input is needed, your GP can refer you to an NHS dermatologist. You may also encounter private trichologists; it is important to be aware that trichology is not a regulated medical specialty in the UK, and trichologists are not medical doctors. They do not form part of NHS referral pathways.

If you have recently started taking ashwagandha or any other supplement and are concerned it may be contributing to hair loss, inform your GP or pharmacist about all supplements you are taking. A pharmacist can provide initial guidance on potential interactions with prescribed medicines. Stopping the supplement temporarily, under professional guidance, may help clarify whether it is a contributing factor — but this decision should be made in discussion with a healthcare professional.

Safety Considerations and MHRA Guidance on Ashwagandha

Ashwagandha carries documented safety risks including rare hepatotoxicity reported to the MHRA, potential thyroid stimulation, and is contraindicated in pregnancy; suspected adverse effects should be reported via the MHRA Yellow Card scheme.

Experiencing these side effects? Our pharmacists can help you navigate them →

From a regulatory standpoint, ashwagandha supplements in the UK are governed by food supplement legislation rather than medicines law. As noted above, there is currently no Traditional Herbal Registration (THR) for any ashwagandha product on the MHRA THR public register, and the European Medicines Agency's Committee on Herbal Medicinal Products (EMA/HMPC) has not issued a formal herbal monograph for ashwagandha. Safety data from long-term human studies therefore remains limited.

Known safety concerns associated with ashwagandha include:

• Liver toxicity: There have been rare but documented case reports of hepatotoxicity (liver injury) associated with ashwagandha supplementation, and the MHRA has received Yellow Card reports of suspected liver adverse events linked to its use. Individuals with pre-existing liver conditions should avoid ashwagandha. If you develop any of the following symptoms whilst taking ashwagandha, stop taking it immediately and seek urgent medical attention: yellowing of the skin or whites of the eyes (jaundice), dark urine, pale stools, severe itching, or pain in the upper right abdomen.

• Thyroid stimulation: Case reports suggest ashwagandha may increase thyroid hormone levels, making it potentially unsuitable for those with hyperthyroidism or those taking thyroid medication. Anyone with a thyroid condition should seek medical advice before use.

• Hormonal effects: Due to possible androgenic activity, individuals with hormone-sensitive conditions should seek medical advice before use. The evidence base for this concern is limited, and caution is advised as a precautionary measure.

• Pregnancy and breastfeeding: Ashwagandha is not recommended during pregnancy, as it has been associated with uterine stimulation in some sources. Those who are breastfeeding should also avoid it, as there is insufficient safety data. The NHS advises general caution with herbal remedies during pregnancy and breastfeeding.

In summary, while there is no confirmed clinical link between ashwagandha and hair loss, the supplement is not without risk. Anyone considering its use should consult a GP or pharmacist beforehand, purchase from reputable suppliers, and report any suspected adverse effects via the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Frequently Asked Questions